Log in to your Inderes Free account to see all free content on this page.
ChemoMetec
401.80 DKK
+0.30 %
Less than 1K followers
CHEMM
NASDAQ Copenhagen
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Dividend
Investor consensus
Valuation
Income statement
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for ChemoMetec
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 175.5 | 214.1 | 281.1 | 427.2 | 442.3 | 407.4 | 495.6 | |
| growth-% | 22.0 % | 31.3 % | 51.9 % | 3.5 % | -7.9 % | 21.7 % | ||
| EBITDA | 64.9 | 92.6 | 135.6 | 222.9 | 251.0 | 186.2 | 258.1 | - |
| EBIT | 54.1 | 77.5 | 116.0 | 202.9 | 230.6 | 169.0 | 236.5 | - |
| Profit before taxes | 53.7 | 75.9 | 112.7 | 203.2 | 230.4 | 176.6 | 240.0 | |
| Net income | 41.8 | 59.2 | 88.4 | 159.5 | 178.7 | 136.3 | 186.4 | - |
| EPS | 2.40 | 3.51 | 5.24 | 9.16 | 10.27 | 7.83 | 10.71 | - |
| Dividend | 13.00 | 20.50 | 4.00 | 0.00 | 6.00 | 4.00 | 7.00 | 0.00 |
| Dividend ratio | 540.6 % | 584.0 % | 76.3 % | 0.0 % | 58.4 % | 51.1 % | 65.4 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| EBITDA-% | 37.0 % | 43.3 % | 48.2 % | 52.2 % | 56.8 % | 45.7 % | 52.1 % | |
| EBIT-% | 30.8 % | 36.2 % | 41.3 % | 47.5 % | 52.1 % | 41.5 % | 47.7 % | |
| ROE | 24.1 % | 29.2 % | 33.3 % | 44.6 % | 33.5 % | 24.1 % | 27.7 % | |
| ROI | 17.6 % | 22.5 % | 25.6 % | 31.8 % | 27.2 % | 20.1 % | 22.5 % |
Login required
This content is only available for logged in users